Cargando…

Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System

Differential diagnosis of COVID-19 and/or influenza (flu) at point of care is critical for efficient patient management and treatment of both these diseases. The study presented here characterizes the BD Veritor System for Rapid Detection of SARS-CoV-2 and Flu A+B (“Veritor SARS-CoV-2/Flu”) triplex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christensen, Katherine, Ren, Huimiao, Chen, Shirley, Cooper, Charles K., Young, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045085/ https://www.ncbi.nlm.nih.gov/pubmed/35412847 http://dx.doi.org/10.1128/spectrum.01807-21

Ejemplares similares

Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test
por: Young, Stephen, et al.
Publicado: (2020)

Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
por: Cooper, Lauren, et al.
Publicado: (2023)

Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system
por: Paradis, Sonia, et al.
Publicado: (2021)

Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19
por: Kilic, Abdullah, et al.
Publicado: (2021)

Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic Patients
por: Koga, Paula, et al.
Publicado: (2022)

Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: A diagnostic accuracy study
por: Kepczynski, Casey M., et al.
Publicado: (2021)

Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System
por: Yanson, Karen, et al.
Publicado: (2021)

Analytical performance of the BD veritor™ system for rapid detection of influenza virus A and B in a primary healthcare setting
por: Mese, Sevim, et al.
Publicado: (2016)

Comparative Clinical Evaluation of a Novel FluA/FluB/SARS-CoV-2 Multiplex LAMP and Commercial FluA/FluB/SARS-CoV-2/RSV RT-qPCR Assays
por: Jee, Hyunseul, et al.
Publicado: (2023)

Evaluation of the point-of-care Becton Dickinson Veritor™ Rapid influenza diagnostic test in Kenya, 2013–2014
por: Ndegwa, Linus K., et al.
Publicado: (2017)

Understanding false positives and the detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and BD MAX SARS-CoV-2 assays
por: Navarathna, Dhammika H., et al.
Publicado: (2021)

Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAX(TM) System in asymptomatic individuals
por: Yanson, Karen, et al.
Publicado: (2023)

Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay
por: Isles, Nicole, et al.
Publicado: (2022)

Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
por: Giovacchini, Nicla, et al.
Publicado: (2021)

Double insult: flu bug enhances SARS-CoV-2 infectivity
por: Su, Shan, et al.
Publicado: (2021)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test
por: Sluimer, John, et al.
Publicado: (2021)

Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
por: Meletis, Georgios, et al.
Publicado: (2022)

A rapid point of care immunoswab assay for SARS-CoV detection
por: Kammila, Sriram, et al.
Publicado: (2008)

Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2
por: Tolan, Nicole V., et al.
Publicado: (2022)

Clinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections
por: Van Der Pol, Barbara, et al.
Publicado: (2021)

Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens
por: Leung, Eddie Chi-man, et al.
Publicado: (2021)

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
por: Fulford, Thomas S., et al.
Publicado: (2021)

European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test
por: Wolters, Femke, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test
por: Mostafa, Heba H., et al.
Publicado: (2021)

A Novel Strategy for Rapid Fluorescence Detection of FluB and SARS-CoV-2
por: Yang, Zhijin, et al.
Publicado: (2023)

Use of the Ct difference between the Nucleocapside (N) and the Spike (S) or RNA-dependent RNA polymerase (RdRP) genes as a preliminary screening for SARS-CoV-2 variants with the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay: Searching the N in Variants
por: Urrutikoetxea-Gutierrez, Mikel, et al.
Publicado: (2022)

From SARS and avian flu to swine flu
por: Wong, G.W.K.
Publicado: (2010)

Performance Evaluation of TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR Multiplex Assay for the Detection of Respiratory Viruses
por: Neopane, Puja, et al.
Publicado: (2022)

Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2
por: Wang, Bo, et al.
Publicado: (2023)

Comparison of the Clinical Performance of the Point-of-care STANDARD M10 SARS-CoV-2 and Xpert Xpress SARS-CoV-2 Assays
por: Hong, Ki Ho, et al.
Publicado: (2023)

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing
por: Conklin, Steven E., et al.
Publicado: (2021)

Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2
por: Pei, Fubin, et al.
Publicado: (2023)

Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays
por: Quinton, Mikayla, et al.
Publicado: (2022)

Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019
por: Basawarajappa, Shantala Gowdara, et al.
Publicado: (2021)

Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers
por: Pallikkuth, Suresh, et al.
Publicado: (2021)

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
por: Syre, Heidi, et al.
Publicado: (2022)

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays
por: Patterson, Edward I, et al.
Publicado: (2020)

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pihk5s6j6m4pk8cct5r3tipf7e